706723 THE CURRENT STATUS OF THYROID DISEASE AMONG THE MARSHALLESE EXPOSED TO FALLOUT FROM THE BRAVO TEST, MARCH 1, 1954 (The following data are taken from an informal report by Dr. Conard dated 4/20/71) The current status may be updated as follows: I. Young Rongelapese exposed to fallout March 1, 1954, when they were 1 to 8 years of age. (Estimated dose: 175 rads external gamma plus 600 to 1400 rem internal irradiation.) ‘Total - 19 Currently. normal by clinical and biochemical tests, (There may be a slight unevenness of the gland in one patient.) . 2 (11%) 3. (16%) 11 (58%) 3 (16%) Currently hypothyroid with minimal nodularity, Responding satisfactorily to oral thyroid hormone therapy. Have undergone surgery in the U, S. prior to 1969 because of nodular thyroid disease; histologic diagnosis of adenomatous goiter and Huerthle cell tumor. Responding satisfactorily to oral thyroid hormone therapy with one exception: This patient shows some enlargement of the remnant.of thyroid left from a partial thyroidectomy in 1964; as she has not followed her post-operative thyroid hormone regimen, there is question as to whether she should have further surgery. Young people operated on for thyroid disease during August 1969 and recovered. Diagnoses: Primary benign adenomatous goiter in two and papillary adenoma of serious grade malignancy in one. (None of six Ailinginae children exposed to an estimated external dose of 69 rads have shown thyroid dysfunction.) II. Surviving adult Rongelapese exposed to fallout. (Estimated dose: 175 rads external plus 160 rem internal irradiation.) Total - 34 1. Papillary carcinoma removed surgically at age 41. No recurrence. Taking oral thyroid hormone therapy. 1 repository EeekesTAe couecrion FZLES. BOXxNe. __&0F b 10138 85 . AésHace rslawbs FOLOER 5; $3 PORTS, ETE)